{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:52:55Z","timestamp":1793335975485,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.urology.2025.04.022","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T16:16:54Z","timestamp":1744820214000},"page":"127-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Differential Outcomes in Bladder Cancer After Neoadjuvant Chemotherapy: An International Multi-Institutional Study Comparing Isolated Nodal Disease vs Persistent Muscle-Invasive Disease"],"prefix":"10.1016","volume":"200","author":[{"given":"Andres M.","family":"Acosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcides","family":"Chaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"Gordetsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Bikhet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeboye O.","family":"Osunkoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad T.","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert J.L.H.","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Gonzalez-Peramato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine M.","family":"Cornejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Sui","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Magi-Galluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soroush","family":"Rais-Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2025.04.022_bib1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urology.2025.04.022_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.urology.2025.04.022_bib3","article-title":"A comparative analysis of radical cystectomy with perioperative chemotherapy, chemoradiation therapy, or systemic therapy in patients with clinically advanced node-positive bladder cancer (cN2\/N3)","volume":"13","author":"Garg","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.urology.2025.04.022_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00345-022-04187-w","article-title":"Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3\/4 or cN+\u2009bladder cancer","volume":"41","author":"Wagner","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.eururo.2014.09.007","article-title":"Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer","volume":"67","author":"Zargar","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eururo.2013.06.049","article-title":"Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis","volume":"65","author":"Petrelli","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215286","article-title":"Management of bladder cancer patients with clinical evidence of lymph node invasion (cN+)","volume":"14","author":"Ma\u0142kiewicz","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.urology.2025.04.022_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.juro.2014.03.078","article-title":"The natural history of clinically complete responders to neoadjuvant chemotherapy for urothelial carcinoma of the bladder","volume":"192","author":"Meyer","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4103\/iju.IJU_142_19","article-title":"Trends in the use of neoadjuvant chemotherapy for bladder cancer with nonurothelial variant histology: an analysis of the National Cancer Database","volume":"35","author":"Grant","year":"2019","journal-title":"Indian J Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00345-019-02916-2","article-title":"How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection","volume":"38","author":"Zamboni","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib11","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41467-017-02320-7","article-title":"Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.urology.2025.04.022_bib12","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/1078-0432.CCR-18-1106","article-title":"Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer","volume":"25","author":"Seiler","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2025.04.022_bib13","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41467-022-33980-9","article-title":"Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer","volume":"13","author":"Damrauer","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.urology.2025.04.022_bib14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41379-018-0096-5","article-title":"Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases","volume":"31","author":"Sj\u00f6dahl","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urology.2025.04.022_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2017.05.016","article-title":"Oncologic outcomes for patients with residual cancer at cystectomy following neoadjuvant chemotherapy: a pathologic stage-matched analysis","volume":"72","author":"Bhindi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4143\/crt.2021.365","article-title":"The prognosis and the role of adjuvant chemotherapy for node-positive bladder cancer treated with neoadjuvant chemotherapy followed by surgery","volume":"54","author":"Jeong","year":"2022","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.urology.2025.04.022_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061962","article-title":"Survival outcomes of patients with pathologically proven positive lymph nodes at time of radical cystectomy with or without neoadjuvant chemotherapy","volume":"9","author":"Ploussard","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.urology.2025.04.022_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00345-021-03839-7","article-title":"Occult lymph node metastases in patients without residual muscle-invasive bladder cancer at radical cystectomy with or without neoadjuvant chemotherapy: a nationwide study of 5417 patients","volume":"40","author":"van Hoogstraten","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/BLC-180186","article-title":"The outcome of post-chemotherapy retroperitoneal lymph node dissection in patients with metastatic bladder cancer in the retroperitoneum","volume":"5","author":"Liu","year":"2019","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.urology.2025.04.022_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.euo.2020.06.009","article-title":"Rationale and outcomes for neoadjuvant immunotherapy in urothelial carcinoma of the bladder","volume":"3","author":"Rouanne","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2025.04.022_bib21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/s41379-018-0023-9","article-title":"Reappraisal of HER2 status in the spectrum of advanced urothelial carcinoma: a need of guidelines for treatment eligibility","volume":"31","author":"Moktefi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urology.2025.04.022_bib22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.juro.2006.03.038","article-title":"Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era","volume":"176","author":"Hautmann","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.04.022_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9962397","article-title":"Neoadjuvant chemotherapy improves the immunosuppressive microenvironment of bladder cancer and increases the sensitivity to immune checkpoint blockade","volume":"2022","author":"Luo","year":"2022","journal-title":"J Immunol Res"},{"key":"10.1016\/j.urology.2025.04.022_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1148\/radiol.2019190032","article-title":"Delayed (18)F FDG PET\/CT imaging in the assessment of residual tumors after transurethral resection of bladder cancer","volume":"293","author":"Yan","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.urology.2025.04.022_bib25","article-title":"Emerging biomarkers for predicting bladder cancer lymph node metastasis","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.urology.2025.04.022_bib26","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1177\/10781552211016526","article-title":"Adjuvant pembrolizumab in genomically selected high-risk patients with muscle-invasive bladder cancer","volume":"27","author":"Mar","year":"2021","journal-title":"J Oncol Pharm Pract"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525003450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525003450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T15:27:13Z","timestamp":1751383633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429525003450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":26,"alternative-id":["S0090429525003450"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.04.022","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Outcomes in Bladder Cancer After Neoadjuvant Chemotherapy: An International Multi-Institutional Study Comparing Isolated Nodal Disease vs Persistent Muscle-Invasive Disease","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}